Stefanie Renae Bailey, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunotherapy, Adoptive | 13 | 2024 | 1467 | 1.520 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1896 | 0.340 |
Why?
|
T-Lymphocytes | 11 | 2024 | 10175 | 0.320 |
Why?
|
Antigens, CD19 | 2 | 2019 | 424 | 0.270 |
Why?
|
GPI-Linked Proteins | 2 | 2024 | 469 | 0.230 |
Why?
|
Antigens, Neoplasm | 2 | 2023 | 1985 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3599 | 0.210 |
Why?
|
Glioblastoma | 3 | 2022 | 3481 | 0.180 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3868 | 0.180 |
Why?
|
Endopeptidases | 1 | 2024 | 774 | 0.180 |
Why?
|
Leukemia, B-Cell | 1 | 2019 | 84 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2022 | 552 | 0.160 |
Why?
|
Neoplasms | 3 | 2023 | 22131 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1404 | 0.140 |
Why?
|
Lentivirus | 1 | 2020 | 507 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2020 | 901 | 0.140 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 963 | 0.140 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2019 | 237 | 0.140 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 196 | 0.140 |
Why?
|
Sulfonamides | 1 | 2024 | 1977 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2546 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2022 | 3145 | 0.110 |
Why?
|
5'-Nucleotidase | 1 | 2014 | 161 | 0.110 |
Why?
|
Apoptosis | 3 | 2024 | 9476 | 0.110 |
Why?
|
Adoptive Transfer | 1 | 2015 | 818 | 0.100 |
Why?
|
Interleukin-12 | 1 | 2015 | 577 | 0.100 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 561 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2014 | 998 | 0.080 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 16967 | 0.080 |
Why?
|
Cytokines | 1 | 2022 | 7373 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5367 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3612 | 0.070 |
Why?
|
Mice | 8 | 2024 | 81368 | 0.050 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2023 | 71 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2024 | 410 | 0.050 |
Why?
|
Humans | 15 | 2024 | 760617 | 0.050 |
Why?
|
Transgenes | 1 | 2024 | 1008 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 878 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2024 | 1022 | 0.040 |
Why?
|
Animals | 8 | 2024 | 168201 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9026 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1677 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2019 | 5463 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2015 | 432 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2625 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1226 | 0.030 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1727 | 0.030 |
Why?
|
Apyrase | 1 | 2014 | 373 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4512 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6126 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5110 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2015 | 911 | 0.020 |
Why?
|
Th17 Cells | 1 | 2014 | 793 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7847 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1798 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1963 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2024 | 6340 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2299 | 0.020 |
Why?
|
Antigens, CD | 1 | 2014 | 3998 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2015 | 2722 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10432 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11514 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4571 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29600 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8542 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23416 | 0.010 |
Why?
|
Female | 1 | 2015 | 392148 | 0.000 |
Why?
|